Tag: MHRA
Are Regulatory Bodies Prioritising Drug Company Interests Over Public Safety?
The UKās Medicines & Healthcare Products Regulatory Agency is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression.
